Advertisement
Advertisement
U.S. markets open in 6 hours 56 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Sol-Gel Technologies Ltd. (4SG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
4.2200-0.1000 (-2.31%)
As of 08:01AM CET. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

    Growth trends for TWYNEO and EPSOLAY continue to improve, demonstrating robust uptake by prescribersSol-Gel’s cash runway expected to extend through the end of the first quarter of 2024 NESS ZIONA, Israel, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today financial results for the third qua

  • Simply Wall St.

    Sol-Gel Technologies (NASDAQ:SLGL) investors are sitting on a loss of 45% if they invested a year ago

    Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...

  • GlobeNewswire

    Sol-Gel Technologies Appoints Michael Glezin Vice President, Business Development

    NESS ZIONA, Israel, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today the appointment of Michael Glezin to the position of Vice President, Business Development. In this position, Mr. Glezin will be responsible for identifying new in-licensing business opportunities as well as potential comm

Advertisement
Advertisement